Weight-loss drug producer Novo Nordisk cuts 9000 jobs — and its revenue forecast
New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs.
Trending
- Individuals Pay The Value For Disastrous Immigration Insurance policies
- Supreme Courtroom’s choice on birthright citizenship will rely upon its interpretation of 1 key phrase
- Brownfield Texas Considers Sanctuary Metropolis for the Unborn Ordinance
- Edinburgh Airport grounds flights attributable to IT subject affecting air visitors management supplier | JP
- Veteran DEA Agent Indicted In Alleged Cartel Cash Laundering Operation
- Louisiana AG Murrill Tells New Orleans High Cop: You Can’t Refuse to Assist ICE, CBP
- Rating Saturday’s fights: Roach-Cruz, Foster-Fulton, extra
- Jack Posobiec calls out Netflix over Stranger Issues pedo programming
- NEW: RNC Hits Blue State With Sweeping Election Integrity Lawsuit
- Abigail Spanberger Nominates FBI Agent Who Wrote Memo Concentrating on Catholics for Prime Security Put up